Characterization of a Partially Deleted Heavy-Chain Gene and Its Protein Product Synthesized In Vivo and In Vitro
暂无分享,去创建一个
[1] J. Salmon,et al. Human receptors for immunoglobulin G: key elements in the pathogenesis of rheumatic disease. , 2001, Arthritis and rheumatism.
[2] G. Panayi,et al. Cytokine pathways and joint inflammation in rheumatoid arthritis. , 2001, The New England journal of medicine.
[3] J. Buxbaum. Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease , 2001, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[4] Gaarder,et al. The Amino Acid Sequence of a Monoclonal γ3‐Heavy Chain from a Patient with Articular γ‐Heavy Chain Deposition Disease , 2000, Scandinavian journal of immunology.
[5] K. Anumula,et al. High-yield deblocking of amino termini of recombinant immunoglobulins with pyroglutamate aminopeptidase. , 1998, Analytical biochemistry.
[6] J. Chomilier,et al. Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease. , 1997, Protein engineering.
[7] A. Khamlichi,et al. Structure of abnormal heavy chains in human heavy-chain-deposition disease. , 1995, European journal of biochemistry.
[8] A. Solomon,et al. Primary amyloidosis associated with a novel heavy‐chain fragment (AH amyloidosis) , 1994, American journal of hematology.
[9] B. Chauffert,et al. Heavy-Chain Deposition Disease , 1993 .
[10] J. Brouet,et al. Gamma Heavy Chain “Disease”: Heterogeneity of the Clinicopathologic Features Report of 16 Cases and Review of the Literature , 1989, Medicine.
[11] J. Buxbaum,et al. Gamma heavy chain disease in man. Genomic sequence reveals two noncontiguous deletions in a single gene. , 1988, The Journal of clinical investigation.
[12] D. Hough,et al. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. , 1986, Journal of immunological methods.
[13] L. Hood,et al. gamma Heavy chain disease in man: cDNA sequence supports partial gene deletion model. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[14] J. Buxbaum,et al. Gamma heavy chain disease in man: translation and partial purification of mRNA coding for the deleted protein. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[15] B. Frangione,et al. Repetitive hinge region sequences in human IgG3: isolation of an 11,000-dalton fragment. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[16] K. Sletten,et al. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link? , 1998, Scandinavian journal of rheumatology.
[17] Marie-Paule Lefranc,et al. IMGT, the international ImMunoGeneTics database , 2001, Nucleic Acids Res..